By: admutabilis | Tags: | Comments:
0
Following the integration of Mutabilis’ second programme in ENABLE in April 2018, the ENABLE Portfolio Management Committee has selected a candidate from this programme.
The ENABLE project is supported by the Innovative Medicines Initiative (IMI), a Public-Private Partnership jointly funded by the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Download full press release
You must be logged in to post a comment.